Small molecule vs peptide GLP-1 agonists — binding affinity comparison

Dr.NateNeph said:

The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to…

This is exactly what I could not find anywhere else. Sending this to two other people who asked me the same thing last week.

Adding the clinical framing, because it changes how the question reads. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

TrialNerd_Beth said:

The useful move here is to separate what is established from what is widely repeated.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

One concrete data point for the thread. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

Moderator note: the sourcing question belongs in the vendor section and has been split out.